[1] |
Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J]. J Clin Oncol,2005,23(30): 7703-7720.
|
[2] |
Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary node dissection for node-positive breast cancer[J]. J Clin Oncol,2009,27(18): 2946-2953.
|
[3] |
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer,2010.
|
[4] |
席晨辉,庄大勇,郑鲁明,等.术中冰冻切片联合快速免疫组织化学染色检测乳腺癌前哨淋巴结微转移的临床研究[J/CD]. 中华乳腺病杂志: 电子版,2011,5(4): 408-418.
|
[5] |
Le Frére-Belda MA, Bats AS, Gillaizeau F, et al. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients [J].Int J Cancer,2012,130(10): 2377-2386.
|
[6] |
Iinuma H, Tamura J, Omoto D, et al. Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients[J]. Br J Cancer,2012,107(4): 724-731.
|
[7] |
Van Deurzen CH, van Hillegersberg R, Hobbelink MG, et al.Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases [J]. Cell Oncol,2007,29(6): 497-505.
|
[8] |
Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer[J]. Eur J Surg Oncol,2008,34(2): 129-134.
|
[9] |
Kumar S, Bramlage M, Jacks LM, et al. Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease[J].Ann Surg Oncol,2010,17(11): 2909-2919.
|
[10] |
Ozcinar B, Muslumanoglu M, Igci A, et al. Clinical importance of micrometastasis in sentinel lymph nodes [J].Breast,2011,20(1): 31-33.
|
[11] |
Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer[J]. J Am Coll Surg,2008,206(2): 261-268.
|
[12] |
Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma[J]. Cancer,2001,92(6): 1378-1384.
|
[13] |
Gipponi M, Canavese G, Lionetto R, et al. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases[J]. Eur J Surg Oncol,2006,32(2): 143-147.
|
[14] |
Di Tommaso L, Arizzi C, Rahal D, et al. Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status[J]. Ann Surg,2006,243(5): 706-707.
|
[15] |
Joyce DP,Solon JG,Prichard RS,et al. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer? [J].Surgeon,2012,10(6): 326-329.
|
[16] |
Yi M, Giordano SH, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs.SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database[J]. Ann Surg Oncol,2010,17(suppl 3): 343-351.
|
[17] |
Montagna E, Viale G, Rotmensz N, et al. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure[J].Breast Cancer Res Treat,2009,118(2): 385-394.
|
[18] |
Yegiyants S, Romero LM, Haigh PI, et al. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node[J]. Arch Surg,2010,145(6): 564-569.
|
[19] |
Viehl CT, Langer I, Guller U, et al. Prognostic impact and therapeutic implications of sentinel lymph node micrometastases in early-stage breast cancer patients[J]. J Surg Oncol,2011,103(6): 531-533.
|
[20] |
Galimberti V, Botteri E, Chifu C, et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?[J]. Breast Cancer Res Treat,2011,131(3): 819-825.
|
[21] |
De Boer M, van Deurzen CH, van Dijck JA, et al.Micrometastases or isolated tumor cells and the outcome of breast cancer[J]. N Engl J Med,2009,361(7): 653-663.
|
[22] |
Van Diest PJ, de Boer M, van Deurzen CH, et al.Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome[J]. J Clin Oncol,2010,28(9): e140.
|
[23] |
Gobardhan PD, Elias SG, Madsen EV, et al. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study[J]. Ann Oncol,2009,20(1): 41-48.
|
[24] |
Reed J,Rosman M,Verbanac KM,et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study[J]. J Am Coll Surg,2009,208(3): 333-340.
|
[25] |
Tjan-Heijnen VC, Pepels MJ, de Boer M. Prognostic impact of isolated tumor cells and micrometastases in axillary lymph nodes of breast cancer patients[J]. Breast Dis,2010,31(2): 107-113.
|